688247 宣泰醫藥
按盤價 
10.370 -0.320 (-2.993%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.565 | 5.116 | 9.873 | 21.287 | 24.971 |
| 總資產報酬率 ROA (%) | 6.633 | 4.534 | 8.456 | 16.816 | 19.720 |
| 投入資產回報率 ROIC (%) | 7.282 | 4.890 | 9.309 | 19.005 | 22.599 | 邊際利潤分析 |
| 銷售毛利率 (%) | 51.236 | 55.893 | 71.229 | 78.127 | 81.522 |
| 營業利潤率 (%) | 28.341 | 23.014 | 40.043 | 38.455 | 44.618 |
| 息稅前利潤/營業總收入 (%) | 27.179 | 19.592 | 35.942 | 48.129 | 48.017 |
| 淨利潤/營業總收入 (%) | 25.530 | 20.367 | 37.539 | 42.767 | 38.632 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 94.323 | 81.647 | 65.801 | 62.767 | 80.579 |
| 價值變動淨收益/利潤總額(%) | 6.862 | 17.228 | 22.344 | 3.111 | 17.512 |
| 營業外收支淨額/利潤總額(%) | -0.815 | -4.578 | -1.699 | 18.589 | -0.059 | 償債能力分析 |
| 流動比率 (X) | 8.909 | 10.494 | 10.591 | 6.913 | 3.831 |
| 速動比率 (X) | 7.955 | 9.562 | 10.264 | 6.461 | 3.537 |
| 資產負債率 (%) | 13.461 | 11.116 | 11.638 | 18.551 | 23.880 |
| 帶息債務/全部投入資本 (%) | -2.725 | -0.826 | -0.377 | -2.280 | 9.773 |
| 股東權益/帶息債務 (%) | -3,540.076 | -11,620.942 | -25,208.639 | -4,074.718 | 870.765 |
| 股東權益/負債合計 (%) | 642.884 | 799.583 | 759.286 | 439.047 | 318.762 |
| 利息保障倍數 (X) | -29.111 | -8.114 | -10.472 | 53.844 | 14.018 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 64.532 | 78.167 | 76.120 | 38.113 | 32.022 |
| 存貨周轉天數 (天) | 146.483 | 155.124 | 176.402 | 214.523 | 163.728 |
| 備註： | 即時報價更新時間為 25/12/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
